Form 4: BioLife Solutions Director, Joydeep Goswami, Reports Acquisition of Common Stock

Director Joydeep Goswami reports acquiring 6,876 shares of BioLife Solutions common stock on March 18, 2025, bringing his total holdings to 47,986 shares.

Summary

• On March 18, 2025, Joydeep Goswami, a director of BioLife Solutions Inc. (BLFS), acquired 6,876 shares of common stock.
• The acquisition was made directly.
• Following the transaction, Goswami beneficially owns 47,986 shares of BioLife Solutions common stock.
• The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the measurement date of 01-02-2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. While insider buying can be seen as a positive signal, this is a relatively small transaction and doesn't necessarily indicate a strong bullish outlook.

Positives

• A director increasing their stake in the company can be seen as a positive signal.

Industry Context

This filing is a routine disclosure related to insider trading and is a standard practice for publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder confidence.

Key Dates

Keywords

BioLife Solutions, BLFS, Joydeep Goswami, Director, Stock Acquisition, Form 4, Beneficial Ownership, 2023 Performance Incentive Plan, Restricted Stock